Dispatches From The AAAS

SAN FRANCISCO--Something new was happening at this year's edition of the AAAS annual meeting. In recent years, the paucity of attendees had turned it into something of an embarrassment. This year, scientists turned out in droves - 5,100 paid attendees showed up in San Francisco between Jan. 14 and 19, up from the 4,570 who attended the 1988 meeting in Boston. And there appeared to be more action in the meeting rooms and corridors of the mazelike, megasized Bay City Hilton. Perhaps it was the

| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

SAN FRANCISCO--Something new was happening at this year's edition of the AAAS annual meeting. In recent years, the paucity of attendees had turned it into something of an embarrassment. This year, scientists turned out in droves - 5,100 paid attendees showed up in San Francisco between Jan. 14 and 19, up from the 4,570 who attended the 1988 meeting in Boston. And there appeared to be more action in the meeting rooms and corridors of the mazelike, megasized Bay City Hilton.

Perhaps it was the supercharged Bay Area science environment. Perhaps the speakers were more alluring. Whatever it was, scientists often jammed rooms to overhear provocative views. Stalking the hallways and conference rooms, The Scientist's reporters bagged some of the more intriguing - or just amusing - exchanges.

Chaos reigned in San Francisco: Sessions on applying chaos theory to everything from heartbeats to the stars were so popular that conference ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies